Listed

Zevra Therapeutics, Inc.

ZVRANasdaqCIK 1434647HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$39.7m, Q2 FY2026
Operating income$16.8m, Q2 FY2026
Net income$8.8m, Q2 FY2026
Zevra Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m2.9Revenue, Q3 FY2023, three months to 2023-09-30$2.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure12.9Revenue, Q4 FY2023, three months to 2023-12-31$12.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure3.4Revenue, Q1 FY2024, three months to 2024-03-31$3.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure4.4Revenue, Q2 FY2024, three months to 2024-06-30$4.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure3.7Revenue, Q3 FY2024, three months to 2024-09-30$3.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure12.0Revenue, Q4 FY2024, three months to 2024-12-31$12.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure20.4Revenue, Q1 FY2025, three months to 2025-03-31$20.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure25.9Revenue, Q2 FY2025, three months to 2025-06-30$25.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure26.1Revenue, Q3 FY2025, three months to 2025-09-30$26.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure34.1Revenue, Q4 FY2025, three months to 2025-12-31$34.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure36.2Revenue, Q1 FY2026, three months to 2026-03-31$36.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure39.7Revenue, Q2 FY2026, three months to 2026-06-30$39.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Cost of revenue$m0.1Cost of revenue, Q3 FY2023, three months to 2023-09-30$144.0k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure2.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2024-04-01, accession 0001437749-24-010430. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m5.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$5.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure14.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$14.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure9.9Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$9.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure12.6Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$12.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure16.2Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$16.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure16.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$16.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure19.5Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$19.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure20.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$20.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure16.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$16.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure20.4Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$20.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure20.8Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$20.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure16.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$16.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Operating income$m(15.4)Operating income, Q3 FY2023, three months to 2023-09-30−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure(15.2)Operating income, Q4 FY2023, three months to 2023-12-31−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure(20.5)Operating income, Q1 FY2024, three months to 2024-03-31−$20.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure(23.8)Operating income, Q2 FY2024, three months to 2024-06-30−$23.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure(27.3)Operating income, Q3 FY2024, three months to 2024-09-30−$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure(15.4)Operating income, Q4 FY2024, three months to 2024-12-31−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(5.4)Operating income, Q1 FY2025, three months to 2025-03-31−$5.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure(71.0)Operating income, Q2 FY2025, three months to 2025-06-30−$71.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure4.1Operating income, Q3 FY2025, three months to 2025-09-30$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure9.3Operating income, Q4 FY2025, three months to 2025-12-31$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure52.1Operating income, Q1 FY2026, three months to 2026-03-31$52.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure16.8Operating income, Q2 FY2026, three months to 2026-06-30$16.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Interest expense$m0.4Interest expense, Q3 FY2023, three months to 2023-09-30$366.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure0.8Interest expense, Q4 FY2023, three months to 2023-12-31$756.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-04-01, accession 0001437749-24-010430. Derived: 12-month figure less the 9-month figure.Report this figure0.7Interest expense, Q1 FY2024, three months to 2024-03-31$735.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure2.1Interest expense, Q2 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure2.3Interest expense, Q3 FY2024, three months to 2024-09-30$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure2.2Interest expense, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2025, three months to 2025-03-31$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure2.0Interest expense, Q2 FY2025, three months to 2025-06-30$2.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure2.1Interest expense, Q3 FY2025, three months to 2025-09-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure1.9Interest expense, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure1.7Interest expense, Q1 FY2026, three months to 2026-03-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Income tax$m0.2Income tax, Q3 FY2023, three months to 2023-09-30$177.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure(0.1)Income tax, Q1 FY2024, three months to 2024-03-31−$70.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$70.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure15.4Income tax, Q4 FY2024, three months to 2024-12-31$15.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure1.2Income tax, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure2.2Income tax, Q2 FY2025, three months to 2025-06-30$2.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure(0.4)Income tax, Q3 FY2025, three months to 2025-09-30−$433.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure0.5Income tax, Q4 FY2025, three months to 2025-12-31$501.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure6.9Income tax, Q1 FY2026, three months to 2026-03-31$6.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure4.0Income tax, Q2 FY2026, three months to 2026-06-30$4.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Net income$m(10.4)Net income, Q3 FY2023, three months to 2023-09-30−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure(19.9)Net income, Q4 FY2023, three months to 2023-12-31−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Net income, Q1 FY2024, three months to 2024-03-31−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure(19.9)Net income, Q2 FY2024, three months to 2024-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure(33.2)Net income, Q3 FY2024, three months to 2024-09-30−$33.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure(35.7)Net income, Q4 FY2024, three months to 2024-12-31−$35.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(3.1)Net income, Q1 FY2025, three months to 2025-03-31−$3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure74.7Net income, Q2 FY2025, three months to 2025-06-30$74.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure(0.5)Net income, Q3 FY2025, three months to 2025-09-30−$544.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure12.2Net income, Q4 FY2025, three months to 2025-12-31$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure37.9Net income, Q1 FY2026, three months to 2026-03-31$37.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure8.8Net income, Q2 FY2026, three months to 2026-06-30$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reported(0.48)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure(0.69)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure1.21Diluted EPS, Q2 FY2025, three months to 2025-06-30$1.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure(0.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figurenot reported0.60Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure0.14Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Basic EPS$ per share(0.30)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figurenot reported(0.40)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure(0.48)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure(0.69)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figurenot reported(0.06)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure1.24Basic EPS, Q2 FY2025, three months to 2025-06-30$1.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure(0.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figurenot reported0.62Basic EPS, Q1 FY2026, three months to 2026-03-31$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure0.14Basic EPS, Q2 FY2026, three months to 2026-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure

Balance sheet

Cash and equivalents$145.3m, Q2 FY2026
Long-term debt$0, Q2 FY2026
Shareholders' equity$217.7m, Q2 FY2026
Zevra Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m43.3Cash and equivalents, Q3 FY2023, at 2023-09-30$43.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure43.0Cash and equivalents, FY2023, at 2023-12-31$43.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-12, accession 0001437749-25-007320.Report this figure42.8Cash and equivalents, Q1 FY2024, at 2024-03-31$42.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure39.3Cash and equivalents, Q2 FY2024, at 2024-06-30$39.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001437749-24-026474.Report this figure54.0Cash and equivalents, Q3 FY2024, at 2024-09-30$54.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure33.8Cash and equivalents, FY2024, at 2024-12-31$33.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure37.3Cash and equivalents, Q1 FY2025, at 2025-03-31$37.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure47.7Cash and equivalents, Q2 FY2025, at 2025-06-30$47.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure54.4Cash and equivalents, Q3 FY2025, at 2025-09-30$54.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure62.4Cash and equivalents, FY2025, at 2025-12-31$62.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure95.6Cash and equivalents, Q1 FY2026, at 2026-03-31$95.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure145Cash and equivalents, Q2 FY2026, at 2026-06-30$145.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Current assets$m137Current assets, Q3 FY2023, at 2023-09-30$137.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure86.9Current assets, FY2023, at 2023-12-31$86.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-12, accession 0001437749-25-007320.Report this figure62.9Current assets, Q1 FY2024, at 2024-03-31$62.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure60.9Current assets, Q2 FY2024, at 2024-06-30$60.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026474.Report this figure99.4Current assets, Q3 FY2024, at 2024-09-30$99.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure86.0Current assets, FY2024, at 2024-12-31$86.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure81.6Current assets, Q1 FY2025, at 2025-03-31$81.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure226Current assets, Q2 FY2025, at 2025-06-30$226.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure225Current assets, Q3 FY2025, at 2025-09-30$225.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure223Current assets, FY2025, at 2025-12-31$223.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure230Current assets, Q1 FY2026, at 2026-03-31$230.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure251Current assets, Q2 FY2026, at 2026-06-30$251.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Total assets$m139Total assets, Q3 FY2023, at 2023-09-30$139.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure172Total assets, FY2023, at 2023-12-31$172.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-12, accession 0001437749-25-007320.Report this figure151Total assets, Q1 FY2024, at 2024-03-31$151.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure144Total assets, Q2 FY2024, at 2024-06-30$144.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001437749-24-026474.Report this figure192Total assets, Q3 FY2024, at 2024-09-30$191.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure178Total assets, FY2024, at 2024-12-31$178.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure173Total assets, Q1 FY2025, at 2025-03-31$172.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure256Total assets, Q2 FY2025, at 2025-06-30$256.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure270Total assets, Q3 FY2025, at 2025-09-30$270.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure285Total assets, FY2025, at 2025-12-31$284.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure279Total assets, Q1 FY2026, at 2026-03-31$278.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure303Total assets, Q2 FY2026, at 2026-06-30$302.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Current liabilities$m21.7Current liabilities, Q3 FY2023, at 2023-09-30$21.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure73.7Current liabilities, FY2023, at 2023-12-31$73.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-12, accession 0001437749-25-007320.Report this figure29.9Current liabilities, Q1 FY2024, at 2024-03-31$29.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure30.4Current liabilities, Q2 FY2024, at 2024-06-30$30.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026474.Report this figure34.5Current liabilities, Q3 FY2024, at 2024-09-30$34.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure34.1Current liabilities, FY2024, at 2024-12-31$34.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure27.0Current liabilities, Q1 FY2025, at 2025-03-31$27.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure28.8Current liabilities, Q2 FY2025, at 2025-06-30$28.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure26.1Current liabilities, Q3 FY2025, at 2025-09-30$26.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure39.3Current liabilities, FY2025, at 2025-12-31$39.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure47.0Current liabilities, Q1 FY2026, at 2026-03-31$47.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure48.6Current liabilities, Q2 FY2026, at 2026-06-30$48.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Total liabilities$m71.5Total liabilities, Q3 FY2023, at 2023-09-30$71.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001437749-23-030690.Report this figure110Total liabilities, FY2023, at 2023-12-31$110.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-12, accession 0001437749-25-007320.Report this figure102Total liabilities, Q1 FY2024, at 2024-03-31$102.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure112Total liabilities, Q2 FY2024, at 2024-06-30$111.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001437749-24-026474.Report this figure122Total liabilities, Q3 FY2024, at 2024-09-30$121.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure138Total liabilities, FY2024, at 2024-12-31$138.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure132Total liabilities, Q1 FY2025, at 2025-03-31$131.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure139Total liabilities, Q2 FY2025, at 2025-06-30$139.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure137Total liabilities, Q3 FY2025, at 2025-09-30$137.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure130Total liabilities, FY2025, at 2025-12-31$130.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure72.8Total liabilities, Q1 FY2026, at 2026-03-31$72.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure85.1Total liabilities, Q2 FY2026, at 2026-06-30$85.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Long-term debt$mnot reported5.1Long-term debt, FY2023, at 2023-12-31$5.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-12, accession 0001437749-25-007320.Report this figurenot reported58.3Long-term debt, Q2 FY2024, at 2024-06-30$58.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-14, accession 0001437749-24-026474.Report this figure58.9Long-term debt, Q3 FY2024, at 2024-09-30$58.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure59.5Long-term debt, FY2024, at 2024-12-31$59.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure60.1Long-term debt, Q1 FY2025, at 2025-03-31$60.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure60.7Long-term debt, Q2 FY2025, at 2025-06-30$60.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure61.3Long-term debt, Q3 FY2025, at 2025-09-30$61.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure61.9Long-term debt, FY2025, at 2025-12-31$61.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure0.0Long-term debt, Q1 FY2026, at 2026-03-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure0.0Long-term debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure
Shareholders' equity$m61.5Shareholders' equity, Q3 FY2023, at 2023-09-30$61.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001437749-24-034916.Report this figure61.9Shareholders' equity, FY2023, at 2023-12-31$61.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001434647-26-000011.Report this figure48.8Shareholders' equity, Q1 FY2024, at 2024-03-31$48.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure32.5Shareholders' equity, Q2 FY2024, at 2024-06-30$32.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure69.8Shareholders' equity, Q3 FY2024, at 2024-09-30$69.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure39.7Shareholders' equity, FY2024, at 2024-12-31$39.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure41.0Shareholders' equity, Q1 FY2025, at 2025-03-31$41.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure117Shareholders' equity, Q2 FY2025, at 2025-06-30$117.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure133Shareholders' equity, Q3 FY2025, at 2025-09-30$133.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure155Shareholders' equity, FY2025, at 2025-12-31$154.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure206Shareholders' equity, Q1 FY2026, at 2026-03-31$205.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure218Shareholders' equity, Q2 FY2026, at 2026-06-30$217.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure

Cash flow

Operating cash flow$17.0m, Q2 FY2026
Capital expenditure$217.0k, Q2 FY2026
Share repurchases$0, Q4 FY2024
Zevra Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(4.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001437749-24-034916. Derived: 9-month figure less the 6-month figure.Report this figure(16.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$16.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure(16.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$16.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure(19.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001628280-25-039967. Derived: 6-month figure less the 3-month figure.Report this figure(18.1)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$18.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001434647-25-000011. Derived: 9-month figure less the 6-month figure.Report this figure(16.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure(3.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001434647-26-000068. Derived: 6-month figure less the 3-month figure.Report this figure4.7Operating cash flow, Q3 FY2025, three months to 2025-09-30$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001434647-25-000011. Derived: 9-month figure less the 6-month figure.Report this figure5.5Operating cash flow, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure6.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure17.0Operating cash flow, Q2 FY2026, three months to 2026-06-30$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001434647-26-000068. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$172.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001437749-24-034916. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001437749-25-016523.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001628280-25-039967. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001434647-25-000011. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$99.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure0.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$213.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001434647-26-000068. Derived: 6-month figure less the 3-month figure.Report this figure0.6Capital expenditure, Q3 FY2025, three months to 2025-09-30$554.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001434647-25-000011. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001434647-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$35.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$217.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001434647-26-000068. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001437749-24-034916. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-05-09, accession 0001437749-24-015705.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-08-14, accession 0001437749-24-026474. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001437749-24-034916. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-12, accession 0001437749-25-007320. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)61.34m, Q2 FY2026
Zevra Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20192019-09-30Q2 FY20202020-06-30Q3 FY20202020-09-30Q2 FY20212021-06-30Q3 FY20212021-09-30Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares31.7Diluted shares (weighted), Q3 FY2019, three months to 2019-09-3031,672,149 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2020-10-30, accession 0001437749-20-022028.Report this figure3.9Diluted shares (weighted), Q2 FY2020, three months to 2020-06-303,947,728 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2021-08-13, accession 0001437749-21-019912.Report this figure4.4Diluted shares (weighted), Q3 FY2020, three months to 2020-09-304,425,474 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2021-11-10, accession 0001437749-21-026201.Report this figure29.2Diluted shares (weighted), Q2 FY2021, three months to 2021-06-3029,174,565 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2021-08-13, accession 0001437749-21-019912.Report this figure35.2Diluted shares (weighted), Q3 FY2021, three months to 2021-09-3035,217,953 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2021-11-10, accession 0001437749-21-026201.Report this figure41.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3041,899,087 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001628280-25-039967.Report this figure47.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3047,808,817 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure54.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3154,095,543 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure56.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3056,324,903 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure56.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3055,951,572 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001434647-25-000011.Report this figure60.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3160,230,490 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001434647-26-000031.Report this figure61.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3061,336,617 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure

Shares outstanding: 59.38mShares outstanding, period not labelled, at 2026-07-3159,383,781 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001434647-26-000068.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.